buprenorphine transdermal system 10 ug/h
buprenorphine · PATCH, EXTENDED RELEASE · Alvogen Inc.
buprenorphine transdermal system is a patch, extended release containing buprenorphine at 10 ug/h, taken transdermal. Manufactured by Alvogen Inc..
Key Facts
- Brand Name
- buprenorphine transdermal system
- Generic Name
- buprenorphine
- NDC Code (Product)
47781-407- Manufacturer
- Alvogen Inc.
- Strength
- 10 ug/h
- Dosage Form
- PATCH, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Marketing Status
- DEA Schedule
- Schedule III (Controlled)
- Application #
- ANDA207490
- Drug Class
- Partial Opioid Agonist [EPC]
- Marketing Start
- 05/17/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is buprenorphine transdermal system used for?
buprenorphine transdermal system contains buprenorphine. It is a patch, extended release taken transdermal. Consult your doctor for specific uses.
Is buprenorphine transdermal system a controlled substance?
Yes, buprenorphine transdermal system is classified as CIII under the DEA Controlled Substances Act.
What is the generic name for buprenorphine transdermal system?
The generic name for buprenorphine transdermal system is buprenorphine. There are 11 other brand versions of buprenorphine.
What is the NDC code for buprenorphine transdermal system 10 ug/h?
The NDC (National Drug Code) for buprenorphine transdermal system 10 ug/h is 47781-407, listed by Alvogen Inc..
Other Buprenorphine Brands
See all →- Buprenorphine and Naloxone2 mg/172162-1346
- Buprenorphine8 mg/10904-7155
- Suboxone8 mg/112496-1208
- Buprenorphine7.5 ug/h0093-3239
- Buprenorphine and Naloxone8 mg/131722-481
- Buprenorphine20 ug/h3215-1525
- BUPRENORPHINE8 mg/142858-502
- Buprenorphine5 ug/h42858-750
- BUPRENORPHINE8 mg/150090-5805
- Buprenorphine8 mg/150268-129
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)